The costs of treating type 2 diabetes complications

February 6, 2018, Helmholtz Association of German Research Centres

Scientists at the Helmholtz Zentrum München have examined health insurance data of more than 300,000 people with diabetes in Germany. Their report, published in the medical journal Diabetes Care, breaks down the costs involved in treating complications of the disease. The Helmholtz authors are members of the German Center for Diabetes Research (DZD).

It is estimated that around 7 million people in Germany have type 2 diabetes. Even in its early stages, the disease can cause damage to blood vessels and other organs. This includes eye conditions that can lead to blindness, kidney damage that can result in renal failure, foot problems that may make amputation necessary and serious cardiovascular diseases including myocardial infarction or .

"We wanted to know the extent of the associated that are borne by the statutory health insurance and thus by society as a whole," says first author Katharina Kähm, summing up the aim of the study. The doctoral candidate and her colleagues from the Institute of Health Economics and Health Care Management (IGM) at the Helmholtz Zentrum München therefore examined the data of 316,220 people with type 2 diabetes from the years 2012 to 2015.

High health care costs associated with complications of type 2 diabetes

Based on this data, the researchers made a detailed assessment of the costs of diabetes-related complications. Since type 2 diabetes is most prevalent in older adults, they calculated costs for a man between the ages of 60 and 69. In the quarter in which the respective complication occurred, costs were estimated as follows:

  • eye disease (retinopathy) approx. 700 euros
  • blindness approx. 3,000 euros
  • kidney damage approx. 3,400 euros
  • (dialysis-dependent) renal failure approx. 23,000 euros
  • diabetic foot approx. 1,300 euros
  • amputation approx. 14,000 euros

"Furthermore, the costs associated with cardio- and cerebrovascular disease range from 2,700 for angina pectoris to 20,000 euros for fatal ischemic heart disease," adds Dr. Michael Laxy, who heads the working group at the IGM. "And in the quarters following the initial occurrence of these complications, the costs remain at a high level."

The study is the first of its kind to be conducted on such a large scale and in such detail, the authors say. The long-term aim is to improve prevention programs: "The results show clinical and policy decision makers the considerable financial consequences of diabetes-related complications," says Prof. Rolf Holle. "The study can thus be helpful in the planning and prioritization of new prevention and treatment programs in the management of type 2 ." In the future, group leader Michael Laxy and his team aim to examine the economic impact of multiple co-existing diseases.

Explore further: Weight loss surgery improves microvascular complications in obese diabetic patients

More information: Katharina Kähm et al. Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany, Diabetes Care (2018). DOI: 10.2337/dc17-1763

Related Stories

Weight loss surgery improves microvascular complications in obese diabetic patients

February 5, 2018
In a BJS (British Journal of Surgery) analysis of published studies in obese patients with type 2 diabetes, researchers found that weight loss surgery helps prevent the development of microvascular complications—which affect ...

Eye and heart complications are tightly linked in type 1 diabetes

January 31, 2018
In people with type 1 diabetes, high levels of blood glucose eventually can harm blood vessels in the eye, kidney, heart and other organs—but the damage may be inflicted by different biological mechanisms in different organs. ...

Diabetes-related mortality in Germany higher than expected

November 22, 2017
In the October 2017 issue of the journal Diabetes Care, DDZ scientists published their study on the number of deaths in Germany due to diabetes and its complications. The number of diabetes-related deaths worldwide has doubled ...

Patients at risk over failure to recognize important diabetes subtype

October 23, 2017
The health of people with diabetes is being put at risk due to the failure of doctors to recognise which type of diabetes they have, a new study in the journal Diabetes Care reports.

Good self-management helps to reduce diabetic mortality

March 26, 2014
People with type 2 diabetes who report good self-management behavior have a reduced mortality risk. This was the result of a population-based study conducted by scientists at Helmholtz Zentrum München emphasizing the great ...

Nearly one in four hospitalized patients has diabetes

August 24, 2017
One in four patients in a university hospital suffers from diabetes (22 percent), and again as many suffer from prediabetes (24 percent). These were the findings of a current study by researchers in Tübingen of the German ...

Recommended for you

Deep brain stimulation found to improve diabetes symptoms

May 24, 2018
A team of researchers from several institutions in the Netherlands and Yale University in the U.S. has found evidence that suggests deep brain stimulation (DBS) can help treat type 2 diabetes. In their paper published in ...

Women with pregnancy-related diabetes may be at risk for chronic kidney disease

May 21, 2018
Gestational diabetes may predispose women to early-stage kidney damage, a precursor to chronic kidney disease, according to a study by researchers at the National Institutes of Health and other institutions. The study appears ...

Diabetes researchers find switch for fatty liver disease

May 17, 2018
Duke researchers have identified a key fork in the road for the way the liver deals with carbohydrates, fats and protein. They say it could be a promising new target for combating the pandemics of fatty liver disease and ...

New study of youth with type 1 diabetes connects 'honeymoon period' with lower LDL cholesterol

May 17, 2018
A new study by UMass Medical School physician-scientist Benjamin U. Nwosu, MD, finds that children with type 1 diabetes who experienced a partial clinical remission, or "honeymoon phase," had significantly lower low-density ...

"Living drug factories" may one day replace injections

May 17, 2018
Patients with diabetes generally rely on constant injections of insulin to control their disease. But MIT spinout Sigilon Therapeutics is developing an implantable, insulin-producing device that may one day make injections ...

Boosting the effects of vitamin D to tackle diabetes

May 10, 2018
More than 27 million people in the United States are living with type 2 diabetes, according to the Centers for Disease Control and Prevention. As the population ages and a growing percentage of people become overweight or ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.